PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $53.3 million versus the consensus estimate of $50.1 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.